171 related articles for article (PubMed ID: 12465754)
1. Vitamin D-related therapies in prostate cancer.
Johnson CS; Hershberger PA; Trump DL
Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor: a potential target for intervention.
Johnson CS; Hershberger PA; Bernardi RJ; Mcguire TF; Trump DL
Urology; 2002 Sep; 60(3 Suppl 1):123-30; discussion 130-1. PubMed ID: 12231068
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
Trump DL; Hershberger PA; Bernardi RJ; Ahmed S; Muindi J; Fakih M; Yu WD; Johnson CS
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):519-26. PubMed ID: 15225831
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
5. The antitumor efficacy of calcitriol: preclinical studies.
Johnson CS; Muindi JR; Hershberger PA; Trump DL
Anticancer Res; 2006; 26(4A):2543-9. PubMed ID: 16886662
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
7. Development of weekly high-dose calcitriol based therapy for prostate cancer.
Beer TM
Urol Oncol; 2003; 21(5):399-405. PubMed ID: 14670552
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.
Trump DL; Potter DM; Muindi J; Brufsky A; Johnson CS
Cancer; 2006 May; 106(10):2136-42. PubMed ID: 16598750
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D in Prostate Cancer.
Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
[TBL] [Abstract][Full Text] [Related]
11. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.
Wang JY; Swami S; Krishnan AV; Feldman D
Prostate; 2012 Nov; 72(15):1628-37. PubMed ID: 22457201
[TBL] [Abstract][Full Text] [Related]
12. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A.
Rashid SF; Moore JS; Walker E; Driver PM; Engel J; Edwards CE; Brown G; Uskokovic MR; Campbell MJ
Oncogene; 2001 Apr; 20(15):1860-72. PubMed ID: 11313934
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model.
Ahmed S; Johnson CS; Rueger RM; Trump DL
J Urol; 2002 Aug; 168(2):756-61. PubMed ID: 12131364
[TBL] [Abstract][Full Text] [Related]
14. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
15. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
16. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
[TBL] [Abstract][Full Text] [Related]
17. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
Yin Y; Ni J; Chen M; Guo Y; Yeh S
Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
[TBL] [Abstract][Full Text] [Related]
18. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.
Flynn G; Chung I; Yu WD; Romano M; Modzelewski RA; Johnson CS; Trump DL
Oncology; 2006; 70(6):447-57. PubMed ID: 17237620
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer cells.
Ben-Eltriki M; Deb S; Adomat H; Tomlinson Guns ES
J Steroid Biochem Mol Biol; 2016 Apr; 158():207-219. PubMed ID: 26709138
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
Gupta S; Hussain T; Mukhtar H
Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]